These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Embryonic dopamine cell implants as a treatment for the second phase of Parkinson's disease. Replacing failed nerve terminals. Freed CR; Breeze RE; Rosenberg NL; Schneck SA Adv Neurol; 1993; 60():721-8. PubMed ID: 8420217 [No Abstract] [Full Text] [Related]
23. [Intracerebral cograft of Schwann's cells and fetal adrenal medulla in the treatment of Parkinson's disease]. Zhang WC Zhonghua Wai Ke Za Zhi; 1992 Nov; 29(12):750-2, 797. PubMed ID: 1618035 [TBL] [Abstract][Full Text] [Related]
24. [Parkinson disease: transplantation of embryonic brain tissue]. Hirschelmann R Med Monatsschr Pharm; 1993 Sep; 16(9):274-6. PubMed ID: 8412978 [No Abstract] [Full Text] [Related]
27. Long-term follow-up in 10 Parkinson's disease patients subjected to fetal brain grafting into a cavity in the caudate nucleus: the Clinica Puerta de Hierro experience. CPH Neural Transplantation Group. López-Lozano JJ; Bravo G; Brera B; Dargallo J; Salmeán J; Uría J; Insausti J; Millán I Transplant Proc; 1995 Feb; 27(1):1395-400. PubMed ID: 7878925 [No Abstract] [Full Text] [Related]
28. Interference with anoikis-induced cell death of dopamine neurons: implications for augmenting embryonic graft survival in a rat model of Parkinson's disease. Marchionini DM; Collier TJ; Camargo M; McGuire S; Pitzer M; Sortwell CE J Comp Neurol; 2003 Sep; 464(2):172-9. PubMed ID: 12898610 [TBL] [Abstract][Full Text] [Related]
29. The role of surgery in Parkinson's disease management. Olanow CW; Marsden CD; Lang AE; Goetz CG Neurology; 1994 Mar; 44(3 Suppl 1):S17-20. PubMed ID: 8121577 [No Abstract] [Full Text] [Related]
31. [Cografting technique in the treatment of Parkinson's disease]. Date I; Asari S; Nishimoto A; Felten D No Shinkei Geka; 1991 Oct; 19(10):919-24. PubMed ID: 1944775 [TBL] [Abstract][Full Text] [Related]
32. [Intraparenchymal and intraventricular transplantation of fetal substantia nigra cell suspension in rat model of Parkinson's disease]. Yang H; Zhang K; Cai W Zhonghua Wai Ke Za Zhi; 1997 Jan; 35(1):19-21. PubMed ID: 10374501 [TBL] [Abstract][Full Text] [Related]
33. Adrenal chromaffin cells as transplants in animal models of Parkinson's disease. Hansen JT; Bing GY; Notter MF; Kordower JH; Fiandaca MS; Gash DM J Electron Microsc Tech; 1989 Aug; 12(4):308-15. PubMed ID: 2671302 [TBL] [Abstract][Full Text] [Related]
35. Ethical challenges in cell-based interventions for neurological conditions: some lessons to be learnt from clinical transplantation trials in patients with Parkinson's disease. Hildt E Am J Bioeth; 2009 May; 9(5):37-8. PubMed ID: 19396682 [No Abstract] [Full Text] [Related]
36. Transplants in Parkinson's disease. Lindvall O Eur Neurol; 1991; 31 Suppl 1():17-27. PubMed ID: 1855521 [TBL] [Abstract][Full Text] [Related]